NEWS
< back to news list

NanoGroup invites you to an investor chat: “NanOX System – what is it?”

NanoGroup S.A. cordially invites all interested parties to participate in the investor chat, which will be held on Monday, October 28, 2024 at 3:00 p.m. on the Stockwatch.pl portal.

The meeting will be attended by:

  • Przemysław Mazurek, President of the Management Board,
  • Piotr Mierzejewski, Vice President of the Management Board,
  • Piotr Burliński, Operations Director.

Representatives of the company will present key information regarding the development of the NanOX system – a unique solution designed for the perfusion of organs collected for transplantation in extracorporeal conditions. They will also answer questions regarding research and development works, as well as plans related to the commercialization of the system.

Main chat topics:

  • NanOX System – key information: presentation of the market in which we operate and the main assumptions of the project
  • NanOX Device vs. NanOX Fluid: Discussing Two Independent But Complementary System Components
  • Project phases: details about system development and implementation at different stages
  • Comparison with existing solutions: how our technology compares to competitive products available on the market
  • Partners and subcontractors: cooperation with key partners who support us in production and implementation processes
  • Commercialization Principles: Discussion of Agreements and NanOX Market Introduction Strategy

The chat will also feature visuals, including photos and videos from isolated organ perfusion studies, that will illustrate key stages of our research and development work.

When: Monday, October 28, 2024

Time: 15.00

Where: Stockwatch.pl portal

We encourage you to participate and ask questions about NanoGroup’s innovative solutions. The investor chat is an excellent opportunity to learn more about our activities and plans related to the development of groundbreaking medical technologies that have the potential to revolutionize the transplant market.

Copyright © NanoGroup 2024

Prof. Tomasz Ciach

Founder, Member of the Management Board of NANOGROUP S.A.

Nanotechnology expert. Professor at the Faculty of Chemical and Processing Engineering, Warsaw University of Technology, head of the Biotechnology and Bioprocessing Division. Author of two technologies that are already in production stage, 12 granted patents and over 50 publications. Founder of BioMedLab research group, consultant in numerous companies (AstraZeneca, Procter and Gamble, Reckit, Adamed, Balton, Galmed). Work on various aspects of Biomedical Engineering, mostly on biomedical nanotechnology, active coatings for medical implants, nanoparticles for cancer treatment, biodegradable and nonbiodegradable implants, bone and vascular prosthesis. He gives rare, but already brilliant example of how brave ideas become socially and financially valuable.

Piotr Mierzejewski

Vice President of the Management Board of NANOGROUP S.A.

Clinical pharmacology specialist, former advisor to the Minister of Health on drug policy. He negotiated Poland’s accession to the EU in the field of pharmacy, responsible for the implementation of EU directives in the field of pharmacy into the Polish legal system. Co-founder of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products. Owner of a consulting company cooperating with international pharmaceutical companies in the field of introducing new technologies to the Polish market.

Przemysław Mazurek

President of the Management Board of NANOGROUP S.A.

Associated with the health market since 2004. As Managing Director, he restructured and developed the most dynamically operating Medical Center in the Podkarpacie region, creating and setting new standards of customer service quality on the market. Co-creator of the first solution in Poland for online registration of medical appointments. Co-founder of the first and only Infertility Treatment Clinic (MEDICOR) in Podkarpacie, which he headed as the President until 2009. He was responsible for the development of health insurance in the PZU Group. As Vice President of PZU Pomoc S.A. created the largest medical TPA in Poland to handle health insurance. Co-founder of the first drug insurance in Poland. Since 2015, he has been active in the field of Wealth Management and advises on management and finance. A graduate of International Economic and Political Relations as well as Management and Marketing at the Warsaw School of Economics.

Przemysław Mazurek

President of the Management Board of NANOGROUP S.A.

Associated with the health market since 2004. As Managing Director, he restructured and developed the most dynamically operating Medical Center in the Podkarpacie region, creating and setting new standards of customer service quality on the market. Co-creator of the first solution in Poland for online registration of medical appointments. Co-founder of the first and only Infertility Treatment Clinic (MEDICOR) in Podkarpacie, which he headed as the President until 2009. He was responsible for the development of health insurance in the PZU Group. As Vice President of PZU Pomoc S.A. created the largest medical TPA in Poland to handle health insurance. Co-founder of the first drug insurance in Poland. Since 2015, he has been active in the field of Wealth Management and advises on management and finance. A graduate of International Economic and Political Relations as well as Management and Marketing at the Warsaw School of Economics.